The U.S. federal government shutdown is well into its fourth week, and the FDA budget is still taking a substantial hit as the White House and House Democrats wrangle over immigration policy. FDA Commissioner Scott Gottlieb has taken to Twitter frequently in recent days, stating that while a number of functions have ground to a halt, the agency will focus on safety and thus continue its work on drug and device recalls and routine inspections, the latter of which has been expanded beyond the for-cause inspections initially announced by the agency.